In 2024, Lonza delivered sales of CHF 6.6 billion in line with prior year (-0.2% CER1) CORE EBITDA of CHF 1.9 billion at a margin of 29.0% The CDMO...
Zerion Pharma A/S announces a partnership with Aché Laboratorios Farmacêuticos S.A. (“ACHÉ”), a major Brazilian p...
Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions, has completed the build of its new sterile manufacturing...
Extended Collaboration with Sartorius Powers New Biomanufacturing Lab at McMaster University, Canada State-of-the-art bioprocessing au...
Novo Nordisk announced headline results from STEP UP, a phase 3b trial in the global STEP programme. STEP UP is a 72-week efficacy and safety trial i...
Labviva, the leading AI procurement platform for life sciences, announced the close of its $25 million Series B, bringing its total funding to ...
Atropos Health, a pioneer in translating real-world clinical data into real-world evidence (RWE) for decision-making, today announced i...
Zai Lab Limited announced a new strategic collaboration and worldwide license agreement with MediLink Therapeutics (Suzhou) Co., Ltd. to use MediLi...
CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announced it ...
Innocan Pharma Corporation (the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has closed its previously announced no...
Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, and Serum Institute of India (SII), the world’s...
Lonza has provided an overview of its new “One Lonza” strategy and new organizational structure As Lonza focuses on its core CDMO1 busines...
In this special edition, we explore the cutting-edge advancements, strategies, and visions shaping the biopharma industry in the year ahead. From a...
Matt Boag, Biopharmaceutical Product Marketing Manager at Phenomenex, discusses the transformative innovations shaping plasmid DNA, mRNA, and peptide purif...
© 2026 Biopharma Boardroom. All Rights Reserved.
